SynCore Bio SB04 Dry-AMD in Phase II/III trial
SB04 is an invasive treatment for dry Age-related Macular [...]
SynCore Biotechnology is to Attend ASCO in Chicago, Illinois
SB05 is a paclitaxel component combined with neutral and [...]
SynCore Biotechnology to Participate at the ARVO 2018
SynCore Biotechnology has announced the partnership with Epipole Ltd. [...]
SynCore Biotechnology to Participate at the ChinaBio® Partnering Forum
SynCore Biotechnology announced that the company will attend the [...]
SynCore Biotechnology to Participate at the BIO-EUROPE SPRING – 12th Annual International Partnering Conference
SynCore Biotechnology announced that the company will attend the [...]